Showing 71 - 80 of 36,357
Introduction and objective: In 1983, the launch of cyclosporin was a significant clinical advance for organ transplant recipients. Subsequent drug research led to further advances with the introduction of cyclosporin microemulsion (cyclosporin ME) and tacrolimus. This paper presents the results...
Persistent link: https://www.econbiz.de/10005404781
Objective: The aim of this study was to determine the relative economic consequences of treating asthmatics with twice daily dry powder formoterol 12microg as compared with salmeterol 50microg from a societal perspective. Design and Setting: A randomised, 6-month, open-label study including 482...
Persistent link: https://www.econbiz.de/10005404819
Alcoholism places a considerable economic burden on society. The rate of relapse of previously weaned alcoholics has been shown to decrease following treatment with acamprosate. Therefore, this study investigated the cost effectiveness of acamprosate in the treatment of alcoholism in Germany...
Persistent link: https://www.econbiz.de/10005404846
This paper provides an overview of, and guidance as to when, why and how to choose and use, different simulation modelling methods as applied to healthcare. What simulation is and why it is necessary in addressing healthcare problems are discussed. In addition, key criteria for choosing an...
Persistent link: https://www.econbiz.de/10005404870
Objective: In patients with amyotrophic lateral sclerosis, long term treatment with riluzole has been reported to improve survival or tracheostomy-free survival in comparison with placebo. We conducted a pharmacoeconomic analysis for estimating the cost per life-year gained using this drug....
Persistent link: https://www.econbiz.de/10005404893
The application of Bayesian statistical analyses has been facilitated in recent years by methodological advances and an increasing complexity necessitated within research. Substantial debate has historically accompanied this analytic approach relative to the frequentist method, which is the...
Persistent link: https://www.econbiz.de/10005404905
Objective: Amyotrophic lateral sclerosis (ALS) is a fatal, degenerative neuromuscular disease characterised by a progressive loss of voluntary motor activity. Recombinant human insulin-like growth factor I (rhIGF-I) has been shown to be useful in treating ALS. The purpose of this study was to...
Persistent link: https://www.econbiz.de/10005404963
Objective: The aim of this study was to determine the cost effectiveness of 2 inhaled corticosteroids, fluticasone propionate and flunisolide, in the management of asthma from a third-party payer perspective in Germany (German Sickness Fund). Design and setting: Direct treatment costs were...
Persistent link: https://www.econbiz.de/10005404975
Objective: To undertake a 1-year prospective economic evaluation of ciprofloxacin compared with usual antibacterial care (any antibacterial other than a quinolone) for the treatment of acute exacerbations of chronic bronchitis (AECB) in adults presenting with a type I or type II AECB. Design:...
Persistent link: https://www.econbiz.de/10005404991
Until a few years ago, griseofulvin and ketoconazole were the only 2 oral agents available for the treatment of dermatophyte onychomycosis of the toenails. With the availability of the newer antifungal agents, such as itraconazole, terbinafine and fluconazole, the armamentarium of drugs...
Persistent link: https://www.econbiz.de/10005405008